Product Description: Human CYP2C19, High-Reductase+b5, a recombinant CYP2C19, is a member of the CYP enzyme family. CYP2C19 catalyzes metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs[1].
Formula: N/A
References: [1]Vignaux PA, et al. Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides. Chem Res Toxicol. 2023 Sep 18;36(9):1451-1455.
Molecular Weight: N/A
Research Area: Metabolic Disease
Target: Cytochrome P450